Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2α-ATF4-xCT pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2α-ATF4-xCT pathway

Published:2016-09-30 Issue:45 Volume:7 Page:74132-74151
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wang Sheng-Fan¹²,Chen Meng-Shian¹,Chou Yueh-Ching¹²³,Ueng Yune-Fang¹⁴⁵,Yin Pen-Hui⁶,Yeh Tien-Shun⁷,Lee Hsin-Chen¹

Affiliation:

1. Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan

2. Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan

3. School of Pharmacy, Taipei Medical University, Taipei, Taiwan

4. National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan

5. Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan

6. Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan

7. Institute of Anatomy and Cell Biology, School of Medicine, National Yang-Ming University, Taipei, Taiwan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifaceted role of GCN2 in tumor adaptation and therapeutic targeting;Translational Oncology;2024-11

2. Loss of Gcn2 exacerbates gossypol induced oxidative stress, apoptosis and inflammation in zebrafish;Fish & Shellfish Immunology;2024-08

3. HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancer;Biochemical Pharmacology;2024-07

4. Novel insights into the activating transcription factor 4 in Alzheimer’s disease and associated aging-related diseases: Mechanisms and therapeutic implications;Frontiers in Neuroendocrinology;2024-07

5. TCF12 induces ferroptosis by suppressing OTUB1‐mediated SLC7A11 deubiquitination to promote cisplatin sensitivity in oral squamous cell carcinoma;Cell Biology International;2024-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3